Related Experiment Video
Updated: Aug 15, 2026

03:38
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Bibliometric Analysis of Pulmonary Fibrosis Imaging Research: Knowledge Graph Construction Based on the Web of
Shuo Yu1, Zhiyue Li1, Yuting Zhang2
1School of Medical Technology, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
Summary
Pulmonary fibrosis imaging research is growing, with AI and deep learning emerging as key themes. The field is moving towards quantitative CT biomarkers and AI-driven phenotyping for personalized risk stratification.
Area of Science:
- Medical Imaging
- Pulmonary Medicine
- Radiology
Background:
- Pulmonary fibrosis (PF) imaging research has seen significant growth.
- Understanding publication trends and collaboration networks is crucial for advancing the field.
Purpose of the Study:
- To quantify publication trends in PF imaging from 2015-2024.
- To map international collaboration networks and identify dominant and emerging research themes.
Main Methods:
- A systematic search of Web of Science identified 1,159 articles.
- CiteSpace, VOSviewer, and Scimago Graphica were used for bibliometric analysis, including trend assessment, keyword co-occurrence, and network visualization.
Main Results:
- Publication volume showed sustained linear growth.
- The US and China were leading contributors, with a strong collaboration axis between Western Europe and North America.
- Key themes included idiopathic pulmonary fibrosis, high-resolution computed tomography (HRCT), usual interstitial pneumonia (UIP), and survival.
- Deep learning emerged as a significant research burst from 2021-2024.
Conclusions:
- PF imaging research is shifting towards quantitative CT biomarkers and AI-driven phenotyping.
- AI generalizability is hindered by geographic fragmentation and limited multicenter validation.
- Future research should focus on standardized protocols, multicenter validation, and integrating AI with multi-omics for precise prognostics.
